sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Updated 10/6/2026, 9:41 AM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| ARTV Artiva Biotherapeutics, Inc. | Sale | $255,746 | Aslan Fred Chief Executive Officer, Director | 23,429 sh | at $10.92 | Filed Sep 9, 4:02 PM ET | Filing | |
| ARTV Artiva Biotherapeutics, Inc. | Sale | $115,638 | Horan Christopher Chief Tech Operations Officer | 10,366 sh | at $11.16 | Filed Sep 4, 4:04 PM ET | Filing | |
| ARTV Artiva Biotherapeutics, Inc. | Sale | $93,606 | Bush Jennifer COO, CLO, Compliance Officer | 8,391 sh | at $11.16 | Filed Sep 4, 4:03 PM ET | Filing | |
| ARTV Artiva Biotherapeutics, Inc. | Sale | $12,271 | Banerjee Subhashis Chief Medical Officer | 1,100 sh | at $11.16 | Filed Sep 4, 4:03 PM ET | Filing | |
| ARTV Artiva Biotherapeutics, Inc. | Sale | $690,392 | Aslan Fred Chief Executive Officer, Director | 61,888 sh | at $11.16 | Filed Sep 4, 4:02 PM ET | Filing | |
| ARTV Artiva Biotherapeutics, Inc. | Sale | $98,736 | Banerjee Subhashis Chief Medical Officer | 8,222 sh | at $12.01 | Filed Aug 31, 7:06 PM ET | Filing | |
| ARTV Artiva Biotherapeutics, Inc. | Sale | $5,148 | Banerjee Subhashis Chief Medical Officer | 429 sh | at $12.00 | Filed Aug 19, 9:00 PM ET | Filing | |
| ARTV Artiva Biotherapeutics, Inc. | Buy | $455,726 | RA CAPITAL MANAGEMENT, L.P. Director, 10% owner and 5 others | 45,768 sh | at $9.96 | Filed Jul 31, 5:13 PM ET | Filing | |
| ARTV Artiva Biotherapeutics, Inc. | Buy | $412,777 | RA CAPITAL MANAGEMENT, L.P. Director, 10% owner and 5 others | 41,319 sh | at $9.99 | Filed Jul 28, 5:24 PM ET | Filing | |
| ARTV Artiva Biotherapeutics, Inc. | Buy | $2,583,314 | RA CAPITAL MANAGEMENT, L.P. Director, 10% owner and 5 others | 264,586 sh | at $9.76 | Filed Jul 23, 9:22 PM ET | Filing | |
| ARTV Artiva Biotherapeutics, Inc. | Buy | $58,307 | RA CAPITAL MANAGEMENT, L.P. Director, 10% owner and 5 others | 6,522 sh | at $8.94 | Filed Jul 23, 9:21 PM ET | Amended | Filing |
| ARTV Artiva Biotherapeutics, Inc. | Buy | $1,432,119 | RA CAPITAL MANAGEMENT, L.P. Director, 10% owner and 5 others | 160,354 sh | at $8.93 | Filed Jul 20, 6:08 PM ET | Filing | |
| ARTV Artiva Biotherapeutics, Inc. | Buy | $194,040 | RA CAPITAL MANAGEMENT, L.P. Director, 10% owner and 5 others | 21,654 sh | at $8.96 | Filed Jul 14, 7:00 PM ET | Filing |